Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study.
COVID-19 pandemic
Chronic conditions
India
SARS coronavirus
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
08 04 2021
08 04 2021
Historique:
received:
07
12
2020
accepted:
24
03
2021
entrez:
9
4
2021
pubmed:
10
4
2021
medline:
15
4
2021
Statut:
epublish
Résumé
People with chronic conditions are disproportionately prone to be affected by the COVID-19 pandemic but there are limited data documenting this. We aimed to assess the health, psychosocial and economic impacts of the COVID-19 pandemic on people with chronic conditions in India. Between July 29, to September 12, 2020, we telephonically surveyed adults (n = 2335) with chronic conditions across four sites in India. Data on participants' demographic, socio-economic status, comorbidities, access to health care, treatment satisfaction, self-care behaviors, employment, and income were collected using pre-tested questionnaires. We performed multivariable logistic regression analysis to examine the factors associated with difficulty in accessing medicines and worsening of diabetes or hypertension symptoms. Further, a diverse sample of 40 participants completed qualitative interviews that focused on eliciting patient's experiences during the COVID-19 lockdowns and data analyzed using thematic analysis. One thousand seven hundred thirty-four individuals completed the survey (response rate = 74%). The mean (SD) age of respondents was 57.8 years (11.3) and 50% were men. During the COVID-19 lockdowns in India, 83% of participants reported difficulty in accessing healthcare, 17% faced difficulties in accessing medicines, 59% reported loss of income, 38% lost jobs, and 28% reduced fruit and vegetable consumption. In the final-adjusted regression model, rural residence (OR, 95%CI: 4.01,2.90-5.53), having diabetes (2.42, 1.81-3.25) and hypertension (1.70,1.27-2.27), and loss of income (2.30,1.62-3.26) were significantly associated with difficulty in accessing medicines. Further, difficulties in accessing medicines (3.67,2.52-5.35), and job loss (1.90,1.25-2.89) were associated with worsening of diabetes or hypertension symptoms. Qualitative data suggest most participants experienced psychosocial distress due to loss of job or income and had difficulties in accessing in-patient services. People with chronic conditions, particularly among poor, rural, and marginalized populations, have experienced difficulties in accessing healthcare and been severely affected both socially and financially by the COVID-19 pandemic.
Sections du résumé
BACKGROUND
People with chronic conditions are disproportionately prone to be affected by the COVID-19 pandemic but there are limited data documenting this. We aimed to assess the health, psychosocial and economic impacts of the COVID-19 pandemic on people with chronic conditions in India.
METHODS
Between July 29, to September 12, 2020, we telephonically surveyed adults (n = 2335) with chronic conditions across four sites in India. Data on participants' demographic, socio-economic status, comorbidities, access to health care, treatment satisfaction, self-care behaviors, employment, and income were collected using pre-tested questionnaires. We performed multivariable logistic regression analysis to examine the factors associated with difficulty in accessing medicines and worsening of diabetes or hypertension symptoms. Further, a diverse sample of 40 participants completed qualitative interviews that focused on eliciting patient's experiences during the COVID-19 lockdowns and data analyzed using thematic analysis.
RESULTS
One thousand seven hundred thirty-four individuals completed the survey (response rate = 74%). The mean (SD) age of respondents was 57.8 years (11.3) and 50% were men. During the COVID-19 lockdowns in India, 83% of participants reported difficulty in accessing healthcare, 17% faced difficulties in accessing medicines, 59% reported loss of income, 38% lost jobs, and 28% reduced fruit and vegetable consumption. In the final-adjusted regression model, rural residence (OR, 95%CI: 4.01,2.90-5.53), having diabetes (2.42, 1.81-3.25) and hypertension (1.70,1.27-2.27), and loss of income (2.30,1.62-3.26) were significantly associated with difficulty in accessing medicines. Further, difficulties in accessing medicines (3.67,2.52-5.35), and job loss (1.90,1.25-2.89) were associated with worsening of diabetes or hypertension symptoms. Qualitative data suggest most participants experienced psychosocial distress due to loss of job or income and had difficulties in accessing in-patient services.
CONCLUSION
People with chronic conditions, particularly among poor, rural, and marginalized populations, have experienced difficulties in accessing healthcare and been severely affected both socially and financially by the COVID-19 pandemic.
Identifiants
pubmed: 33832478
doi: 10.1186/s12889-021-10708-w
pii: 10.1186/s12889-021-10708-w
pmc: PMC8027966
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
685Subventions
Organisme : FIC NIH HHS
ID : D43 TW010543
Pays : United States
Organisme : FIC NIH HHS
ID : K43 TW011164
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK111024
Pays : United States
Organisme : FIC NIH HHS
ID : U01 TW010097
Pays : United States
Références
BMJ Open. 2018 Jul 10;8(6):e015919
pubmed: 29991625
Minerva Med. 2020 Aug;111(4):297-299
pubmed: 32407045
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33571107
Psychiatr Danub. 2020 Autumn - Winter;32(3-4):472-477
pubmed: 33370755
BMJ. 2020 Mar 25;368:m1174
pubmed: 32213482
Glob Heart. 2020 Apr 09;15(1):31
pubmed: 32489804
Front Psychol. 2019 Aug 06;10:1713
pubmed: 31447721
Proc Natl Acad Sci U S A. 2020 Jul 7;117(27):15530-15535
pubmed: 32554604
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016
Soc Sci Med. 2017 Sep;189:63-75
pubmed: 28787628
J Gen Intern Med. 2020 Oct;35(10):3126-3128
pubmed: 32761284
Health Equity. 2020 Aug 05;4(1):336-344
pubmed: 32783017
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1621-1623
pubmed: 32889403
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Diabetes Technol Ther. 2020 Jul;22(7):527-534
pubmed: 32522031
JMIR Pediatr Parent. 2020 Oct 12;3(2):e23057
pubmed: 33001834
Brain Behav Immun. 2020 Jul;87:184-187
pubmed: 32454138
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464
pubmed: 32298251
Science. 2020 Nov 6;370(6517):691-697
pubmed: 33154136
PLoS One. 2020 Sep 11;15(9):e0238972
pubmed: 32915899
J Affect Disord. 2020 Mar 15;265:395-401
pubmed: 32090765
Cardiovasc Diagn Ther. 2020 Apr;10(2):376-385
pubmed: 32420119
Indian Heart J. 2017 Jul - Aug;69(4):434-441
pubmed: 28822507
Res Social Adm Pharm. 2021 Jan;17(1):1946-1949
pubmed: 32446652
J Epidemiol Community Health. 2021 Jan 5;:
pubmed: 33402397
Front Public Health. 2020 Sep 25;8:508
pubmed: 33102414
Qual Health Res. 2020 Oct;30(12):1899-1912
pubmed: 32449451
Acta Biomed. 2020 May 11;91(2):35-38
pubmed: 32420922
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):129-135
pubmed: 33338951
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1907-1912
pubmed: 33011498
BMC Fam Pract. 2020 Dec 5;21(1):255
pubmed: 33278877
Lancet. 2020 Sep 26;396(10255):867
pubmed: 32979962
PLoS One. 2020 Jun 19;15(6):e0234898
pubmed: 32559246
Lancet. 2020 Jun 20;395(10241):e110-e111
pubmed: 32534627
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Int J Soc Psychiatry. 2020 Jul 2;:20764020939984
pubmed: 32615838
Z Gesundh Wiss. 2020 Nov 13;:1-6
pubmed: 33224715
Health Policy Technol. 2020 Dec;9(4):649-662
pubmed: 32874860
Global Health. 2021 Jan 5;17(1):4
pubmed: 33402169
Lancet. 2020 Sep 5;396(10252):657
pubmed: 32891197
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
BMJ. 2020 May 11;369:m1851
pubmed: 32393532
Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596
pubmed: 28601585
J Gen Intern Med. 2020 Sep;35(9):2784-2787
pubmed: 32578018
BMC Public Health. 2012 Aug 28;12:701
pubmed: 22928740
J Racial Ethn Health Disparities. 2021 Jan 19;:
pubmed: 33469872
Glob Health J. 2020 Dec;4(4):139-145
pubmed: 33312747
Front Public Health. 2020 Dec 11;8:620416
pubmed: 33425843
PLoS One. 2021 Jan 7;16(1):e0244173
pubmed: 33411744